1. Home
  2. IPSC vs PED Comparison

IPSC vs PED Comparison

Compare IPSC & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • PED
  • Stock Information
  • Founded
  • IPSC 2019
  • PED N/A
  • Country
  • IPSC United States
  • PED United States
  • Employees
  • IPSC N/A
  • PED N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • PED Oil & Gas Production
  • Sector
  • IPSC Health Care
  • PED Energy
  • Exchange
  • IPSC Nasdaq
  • PED Nasdaq
  • Market Cap
  • IPSC 62.1M
  • PED 70.3M
  • IPO Year
  • IPSC 2021
  • PED N/A
  • Fundamental
  • Price
  • IPSC $0.73
  • PED $0.76
  • Analyst Decision
  • IPSC Strong Buy
  • PED Strong Buy
  • Analyst Count
  • IPSC 5
  • PED 3
  • Target Price
  • IPSC $11.00
  • PED $1.83
  • AVG Volume (30 Days)
  • IPSC 493.4K
  • PED 127.1K
  • Earning Date
  • IPSC 03-13-2025
  • PED 03-17-2025
  • Dividend Yield
  • IPSC N/A
  • PED N/A
  • EPS Growth
  • IPSC N/A
  • PED 125.69
  • EPS
  • IPSC N/A
  • PED 0.02
  • Revenue
  • IPSC $2,684,000.00
  • PED $35,719,000.00
  • Revenue This Year
  • IPSC $230.60
  • PED $26.32
  • Revenue Next Year
  • IPSC $31.83
  • PED $2.77
  • P/E Ratio
  • IPSC N/A
  • PED $31.26
  • Revenue Growth
  • IPSC 7.88
  • PED 19.19
  • 52 Week Low
  • IPSC $0.68
  • PED $0.65
  • 52 Week High
  • IPSC $5.51
  • PED $1.10
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 30.98
  • PED 43.28
  • Support Level
  • IPSC $0.72
  • PED $0.74
  • Resistance Level
  • IPSC $0.82
  • PED $0.83
  • Average True Range (ATR)
  • IPSC 0.06
  • PED 0.04
  • MACD
  • IPSC 0.01
  • PED 0.00
  • Stochastic Oscillator
  • IPSC 27.43
  • PED 35.18

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: